|
Volumn 13, Issue SUPPL. 1, 2004, Pages
|
Zonisamide overview of the United States experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
PHENOBARBITAL;
PHENYTOIN;
VALPROIC ACID;
ZONISAMIDE;
ANOREXIA;
ATAXIA;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
EPILEPSY;
FOCAL EPILEPSY;
HUMAN;
MORBIDITY;
NEPHROLITHIASIS;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
SOMNOLENCE;
UNITED STATES;
WEIGHT REDUCTION;
|
EID: 7044222470
PISSN: 10591311
EISSN: None
Source Type: Journal
DOI: 10.1016/j.seizure.2004.04.008 Document Type: Letter |
Times cited : (7)
|
References (7)
|